Beyond mean hemoglobin A1c, glycemic variability over time may be an additional risk factor for poor kidney outcomes.
In a study, patients undergoing thrice-weekly extended home hemodialysis had a lower death risk compared with those receiving in-center conventional hemodialysis.
Empagliflozin is a sodium-glucose co-transporter 2 inhibitor.
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events, and mortality in patients on hemodialysis.
Incorporating a combination of urinary biomarkers may help identify patients at the highest risk for CKD progression.
A small study showed that 38% of patients with ANCA-glomerulonephritis vasculitis who underwent for-cause repeat biopsy had active disease.
Preeclampsia is an important risk factor for chronic kidney disease and warrants post-delivery monitoring, according to investigators.
Acute kidney injury did not necessarily explain the study results.
The Kidney Cancer Risk Equation for predicting post-nephrectomy ESKD builds on the ubiquitous Kidney Failure Risk Equation and is easy to use, according to investigators.
Study finds age-, sex-, race and ethnicity-, and social deprivation-related disparities in the timing of preoperative hemodialysis.